董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Ailiang Wang | 女 | Chairman of the board | -- | 未披露 | 未持股 | 2025-09-30 |
| Leyi Lee | 女 | Chief Executive Officer and Director | -- | 未披露 | 未持股 | 2025-09-30 |
| Wenzhang Jia | 男 | Independent Director | 59 | 未披露 | 0.19 | 2025-09-30 |
| Anna Colin | 女 | Independent Director | -- | 未披露 | 未持股 | 2025-09-30 |
| Chongbo Gao | 男 | Independent Director | -- | 未披露 | 未持股 | 2025-09-30 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Leyi Lee | 女 | Chief Executive Officer and Director | -- | 未披露 | 未持股 | 2025-09-30 |
| Shilong Liao | 男 | Chief Financial Officer | -- | 未披露 | 未持股 | 2025-09-30 |
董事简历
中英对照 | 中文 | 英文- Ailiang Wang
-
Ailiang Wang，于2023年10月至2025年9月1日期间担任广州蓝极康医疗科技股份有限公司董事长兼首席执行官，负责制定和实施公司三年战略发展规划，主导核心产品线的研发和商业化，成功获得欧盟CE认证和美国FDA 510（k）产品批准，建立了覆盖欧洲和北美多个国家的国际分销网络，并让重要的B轮融资。在此之前，Ms. Wang于2015年5月至2023年2月担任北京天德泰科技有限公司首席执行官，主导制定公司医疗用品和设备销售五年发展战略并主导构建核心供应商合作体系，与20多家国内外知名医疗设备厂商建立独家或优先代理合作关系。Ms. Wang于1999年获得中南大学湘雅医院医学硕士学位。
Ailiang Wang,served as the Chairwoman and Chief Executive Officer of Guangzhou Lanjikang Medical Technology Co., Ltd. from October 2023 to September 01, 2025 where she formulated and implemented the company's three-year strategic development plan, led the research and development and commercialization of core product lines, successfully obtained EU CE certification and US FDA 510(k) approval for products, established an international distribution network covering multiple countries in Europe and North America, and let an important series B round fundraising. Prior to that, Ms. Wang was the Chief Executive Officer of Beijing tiandetai Technology Co., Ltd.from May 2015 to February 2023 where she led the formulation of the company's five-year development strategy for medical supplies and equipment sales and led the construction of a core supplier cooperation system, establish exclusive or priority agency cooperation relationships with more than 20 well-known domestic and foreign medical equipment manufacturers. Ms. Wang earned her Master of Medicine degree from Xiangya Hospital, Central South University in 1999. - Ailiang Wang，于2023年10月至2025年9月1日期间担任广州蓝极康医疗科技股份有限公司董事长兼首席执行官，负责制定和实施公司三年战略发展规划，主导核心产品线的研发和商业化，成功获得欧盟CE认证和美国FDA 510（k）产品批准，建立了覆盖欧洲和北美多个国家的国际分销网络，并让重要的B轮融资。在此之前，Ms. Wang于2015年5月至2023年2月担任北京天德泰科技有限公司首席执行官，主导制定公司医疗用品和设备销售五年发展战略并主导构建核心供应商合作体系，与20多家国内外知名医疗设备厂商建立独家或优先代理合作关系。Ms. Wang于1999年获得中南大学湘雅医院医学硕士学位。
- Ailiang Wang,served as the Chairwoman and Chief Executive Officer of Guangzhou Lanjikang Medical Technology Co., Ltd. from October 2023 to September 01, 2025 where she formulated and implemented the company's three-year strategic development plan, led the research and development and commercialization of core product lines, successfully obtained EU CE certification and US FDA 510(k) approval for products, established an international distribution network covering multiple countries in Europe and North America, and let an important series B round fundraising. Prior to that, Ms. Wang was the Chief Executive Officer of Beijing tiandetai Technology Co., Ltd.from May 2015 to February 2023 where she led the formulation of the company's five-year development strategy for medical supplies and equipment sales and led the construction of a core supplier cooperation system, establish exclusive or priority agency cooperation relationships with more than 20 well-known domestic and foreign medical equipment manufacturers. Ms. Wang earned her Master of Medicine degree from Xiangya Hospital, Central South University in 1999.
- Leyi Lee
-
Leyi Lee，于2024年2月至2025年8月期间担任DeepMind Health的销售总监，负责领导人工智能驱动的医疗保健解决方案的商业战略。从2019年3月到2024年1月，Ms. Lee在深圳迈瑞担任业务经理，负责推动包括监护仪和超声系统在内的医疗设备的市场增长。2014年2月至2019年2月，她在商汤科技担任销售经理，专注于市场策略和客户获取以及产品-市场契合度优化。Ms. Lee于2015年获得香港理工大学工商管理硕士学位，并于2013年获得香港恒生大学工商管理学士学位（荣誉）。
Leyi Lee,served as the Director of Sales in DeepMind Health from February 2024 until August 2025, where she led commercial strategy for AI-driven healthcare solutions. From March 2019 until January 2024, Ms. Lee was the Business Manager at Mindray Medical International, responsible for driving market growth across medical devices including monitors and ultrasound systems. From February 2014 to February 2019, she was the Sales Manager at SenseTime, focusing on market strategy and client acquisition and product-market fit optimization. Ms. Lee received her master's degree in business administration from The Hong Kong Polytechnic University in 2015 and her bachelor's degree (honorary) in business administration from The Hang Seng University of Hong Kong in 2013. - Leyi Lee，于2024年2月至2025年8月期间担任DeepMind Health的销售总监，负责领导人工智能驱动的医疗保健解决方案的商业战略。从2019年3月到2024年1月，Ms. Lee在深圳迈瑞担任业务经理，负责推动包括监护仪和超声系统在内的医疗设备的市场增长。2014年2月至2019年2月，她在商汤科技担任销售经理，专注于市场策略和客户获取以及产品-市场契合度优化。Ms. Lee于2015年获得香港理工大学工商管理硕士学位，并于2013年获得香港恒生大学工商管理学士学位（荣誉）。
- Leyi Lee,served as the Director of Sales in DeepMind Health from February 2024 until August 2025, where she led commercial strategy for AI-driven healthcare solutions. From March 2019 until January 2024, Ms. Lee was the Business Manager at Mindray Medical International, responsible for driving market growth across medical devices including monitors and ultrasound systems. From February 2014 to February 2019, she was the Sales Manager at SenseTime, focusing on market strategy and client acquisition and product-market fit optimization. Ms. Lee received her master's degree in business administration from The Hong Kong Polytechnic University in 2015 and her bachelor's degree (honorary) in business administration from The Hang Seng University of Hong Kong in 2013.
- Wenzhang Jia
-
Wenzhang Jia是Jiangsu Xibei Electronic Network Co.董事长兼首席财务官，Jiangsu Xibei Electronic Network Co.生产和销售电线电缆、有线电视设备和网络通信设备，自2000年2月起担任该职位。 Jia先生于2004年获得扬州工商学院金融学士学位。 Jia先生自2007年起担任扬州电器工业协会会长。
Wenzhang Jia,has been a director of Company, and the chairman of audit committee, since June 28, 2022. Mr. Jia is the chairman and chief financial officer of Jiangsu Xibei Electronic Network Co., a company that produces and sells wire and cable, cable TV equipment and network communications equipment, a position he has served in since February of 2000. Mr. Jia received his Bachelor's degree in finance in 2004 from Yangzhou Institute of Commerce and Industry.Mr. Jia has been president of the Yangzhou Electrical Appliance Industry Association since 2007. - Wenzhang Jia是Jiangsu Xibei Electronic Network Co.董事长兼首席财务官，Jiangsu Xibei Electronic Network Co.生产和销售电线电缆、有线电视设备和网络通信设备，自2000年2月起担任该职位。 Jia先生于2004年获得扬州工商学院金融学士学位。 Jia先生自2007年起担任扬州电器工业协会会长。
- Wenzhang Jia,has been a director of Company, and the chairman of audit committee, since June 28, 2022. Mr. Jia is the chairman and chief financial officer of Jiangsu Xibei Electronic Network Co., a company that produces and sells wire and cable, cable TV equipment and network communications equipment, a position he has served in since February of 2000. Mr. Jia received his Bachelor's degree in finance in 2004 from Yangzhou Institute of Commerce and Industry.Mr. Jia has been president of the Yangzhou Electrical Appliance Industry Association since 2007.
- Anna Colin
-
Anna Colin，自2024年5月起担任Piper Sandler的首席运营官，负责设计全公司的运营策略并监督新基金发布的监管合规性。Ms. Colin于2022年4月至2024年5月期间在高盛 Sachs担任运营经理，在那里她管理着一个对冲基金客户资产报告和托管的五人团队，并为实时头寸监控设计了风险仪表板。从2021年8月到2022年10月，Ms. Colin在摩根士丹利担任运营分析师，在那里她与风险团队合作调查交易中断、优化运营工作流程并执行股票和固定收益交易的交易后清算和结算。Ms. Colin于2020年获得伦敦政治经济学院金融学硕士学位，并于2019年获得宾夕法尼亚大学沃顿学院金融和经济学学士学位。
Anna Colin,has served as the chief operating officer for Piper Sandler since May 2024, responsible for designing firm-wide operations strategy and overseeing regulatory compliance for new fund launches. Ms. Colin worked as an operations manager in Goldman Sachs from April 2022 to May 2024, where she managed a team of five for hedge fund client asset reporting and custody and designed risk dashboard for real-time position monitoring. From August 2021 to October 2022, Ms. Colin worked as the operations analyst at Morgan Stanley, where she collaborated with risk teams to investigate trade breaks, optimized operational workflows and executed post-trade clearing and settlement for equities and fixed income transactions. Ms. Colin received her master's degree in finance from the London School of Economics and Political Sciences in 2020 and her bachelor's degree in finance and economics from The Warton School of the University of Pennsylvania in 2019. - Anna Colin，自2024年5月起担任Piper Sandler的首席运营官，负责设计全公司的运营策略并监督新基金发布的监管合规性。Ms. Colin于2022年4月至2024年5月期间在高盛 Sachs担任运营经理，在那里她管理着一个对冲基金客户资产报告和托管的五人团队，并为实时头寸监控设计了风险仪表板。从2021年8月到2022年10月，Ms. Colin在摩根士丹利担任运营分析师，在那里她与风险团队合作调查交易中断、优化运营工作流程并执行股票和固定收益交易的交易后清算和结算。Ms. Colin于2020年获得伦敦政治经济学院金融学硕士学位，并于2019年获得宾夕法尼亚大学沃顿学院金融和经济学学士学位。
- Anna Colin,has served as the chief operating officer for Piper Sandler since May 2024, responsible for designing firm-wide operations strategy and overseeing regulatory compliance for new fund launches. Ms. Colin worked as an operations manager in Goldman Sachs from April 2022 to May 2024, where she managed a team of five for hedge fund client asset reporting and custody and designed risk dashboard for real-time position monitoring. From August 2021 to October 2022, Ms. Colin worked as the operations analyst at Morgan Stanley, where she collaborated with risk teams to investigate trade breaks, optimized operational workflows and executed post-trade clearing and settlement for equities and fixed income transactions. Ms. Colin received her master's degree in finance from the London School of Economics and Political Sciences in 2020 and her bachelor's degree in finance and economics from The Warton School of the University of Pennsylvania in 2019.
- Chongbo Gao
-
Chongbo Gao，自2018年3月至2025年9月30日担任博圣（深圳）医疗器械有限公司首席运营官，专注于医疗器械行业全链条发展，具备医疗器械研发转化、临床应用管理、区域产业协同等多方面经验。Mr. Gao于2003年获得广州医科大学医学硕士学位。
Chongbo Gao,has served as the chief operating officer for Bosheng (Shenzhen) Meidical Devices Co., Ltd. from March 2018 to September 30, 2025 where he focused on the full-chain development of the medical device industry, and possess multiple experiences in medical device research and development transformation, clinical application management, and regional industrial coordination. Mr. Gao earned his Master of Medicine degree from Guangzhou Medical University in 2003. - Chongbo Gao，自2018年3月至2025年9月30日担任博圣（深圳）医疗器械有限公司首席运营官，专注于医疗器械行业全链条发展，具备医疗器械研发转化、临床应用管理、区域产业协同等多方面经验。Mr. Gao于2003年获得广州医科大学医学硕士学位。
- Chongbo Gao,has served as the chief operating officer for Bosheng (Shenzhen) Meidical Devices Co., Ltd. from March 2018 to September 30, 2025 where he focused on the full-chain development of the medical device industry, and possess multiple experiences in medical device research and development transformation, clinical application management, and regional industrial coordination. Mr. Gao earned his Master of Medicine degree from Guangzhou Medical University in 2003.
高管简历
中英对照 | 中文 | 英文- Leyi Lee
Leyi Lee，于2024年2月至2025年8月期间担任DeepMind Health的销售总监，负责领导人工智能驱动的医疗保健解决方案的商业战略。从2019年3月到2024年1月，Ms. Lee在深圳迈瑞担任业务经理，负责推动包括监护仪和超声系统在内的医疗设备的市场增长。2014年2月至2019年2月，她在商汤科技担任销售经理，专注于市场策略和客户获取以及产品-市场契合度优化。Ms. Lee于2015年获得香港理工大学工商管理硕士学位，并于2013年获得香港恒生大学工商管理学士学位（荣誉）。
Leyi Lee,served as the Director of Sales in DeepMind Health from February 2024 until August 2025, where she led commercial strategy for AI-driven healthcare solutions. From March 2019 until January 2024, Ms. Lee was the Business Manager at Mindray Medical International, responsible for driving market growth across medical devices including monitors and ultrasound systems. From February 2014 to February 2019, she was the Sales Manager at SenseTime, focusing on market strategy and client acquisition and product-market fit optimization. Ms. Lee received her master's degree in business administration from The Hong Kong Polytechnic University in 2015 and her bachelor's degree (honorary) in business administration from The Hang Seng University of Hong Kong in 2013.- Leyi Lee，于2024年2月至2025年8月期间担任DeepMind Health的销售总监，负责领导人工智能驱动的医疗保健解决方案的商业战略。从2019年3月到2024年1月，Ms. Lee在深圳迈瑞担任业务经理，负责推动包括监护仪和超声系统在内的医疗设备的市场增长。2014年2月至2019年2月，她在商汤科技担任销售经理，专注于市场策略和客户获取以及产品-市场契合度优化。Ms. Lee于2015年获得香港理工大学工商管理硕士学位，并于2013年获得香港恒生大学工商管理学士学位（荣誉）。
- Leyi Lee,served as the Director of Sales in DeepMind Health from February 2024 until August 2025, where she led commercial strategy for AI-driven healthcare solutions. From March 2019 until January 2024, Ms. Lee was the Business Manager at Mindray Medical International, responsible for driving market growth across medical devices including monitors and ultrasound systems. From February 2014 to February 2019, she was the Sales Manager at SenseTime, focusing on market strategy and client acquisition and product-market fit optimization. Ms. Lee received her master's degree in business administration from The Hong Kong Polytechnic University in 2015 and her bachelor's degree (honorary) in business administration from The Hang Seng University of Hong Kong in 2013.
- Shilong Liao
Shilong Liao曾担任Jingguang Da Limited的首席财务官，在那里他领导了融资，从2024年12月到2025年8月，负责监督财务运营以及合规和风险管理。此前，他于2019年1月至2024年10月担任Siemens Healthineers财务总监，负责战略财务规划、财务运营和数字化转型，管理150 +成员财务团队。在此之前，Mr. Liao于2014年6月至2018年12月在凤凰合伙公司担任财务经理，在那里他领导了多轮融资，重新设计了财务流程，并加强了财务控制。Mr. Liao于2006年获得上海财经大学会计学硕士学位，并于2004年获得厦门大学会计学学士学位。
Shilong Liao served as the CFO of Jing Guang Da Limited, where he led fundraising, oversaw financial operations and compliance and risk management from December 2024 until August 2025. Previously, he was Finance Director at Siemens Healthineers from January 2019 to October 2024, responsible for strategic financial planning, financial operations and digital transformation, and managing a 150+ member finance team. Before that, Mr. Liao served as Finance Manager at The Phoenix Partnership from June 2014 to December 2018, where he led multiple rounds of funding, re-engineered financial processes, and strengthened financial controls. Mr. Liao received his master's degree in accounting from Shanghai University of Finance and Economics in 2006 and his bachelor's degree in accounting from Xiamen University in 2004.- Shilong Liao曾担任Jingguang Da Limited的首席财务官，在那里他领导了融资，从2024年12月到2025年8月，负责监督财务运营以及合规和风险管理。此前，他于2019年1月至2024年10月担任Siemens Healthineers财务总监，负责战略财务规划、财务运营和数字化转型，管理150 +成员财务团队。在此之前，Mr. Liao于2014年6月至2018年12月在凤凰合伙公司担任财务经理，在那里他领导了多轮融资，重新设计了财务流程，并加强了财务控制。Mr. Liao于2006年获得上海财经大学会计学硕士学位，并于2004年获得厦门大学会计学学士学位。
- Shilong Liao served as the CFO of Jing Guang Da Limited, where he led fundraising, oversaw financial operations and compliance and risk management from December 2024 until August 2025. Previously, he was Finance Director at Siemens Healthineers from January 2019 to October 2024, responsible for strategic financial planning, financial operations and digital transformation, and managing a 150+ member finance team. Before that, Mr. Liao served as Finance Manager at The Phoenix Partnership from June 2014 to December 2018, where he led multiple rounds of funding, re-engineered financial processes, and strengthened financial controls. Mr. Liao received his master's degree in accounting from Shanghai University of Finance and Economics in 2006 and his bachelor's degree in accounting from Xiamen University in 2004.